Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial

The Centers for Disease Control and Prevention (CDC) has allocated $1.6 million for a study on the alleged harms of the hepatitis B vaccine, sparking outrage among some experts who consider the study unethical. The study aims to investigate the potential side effects of the vaccine, specifically its alleged link to conditions such as multiple sclerosis and Guillain-Barré syndrome. However, many medical professionals view this line of research as unfounded and potentially damaging to public health efforts to combat hepatitis B, which can lead to severe liver disease and liver cancer if left untreated. The study's focus on the vaccine's alleged harms may divert attention away from the vaccine's proven benefits in preventing these conditions.